This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Canada’s health regulator has approved Novo Nordisk’s weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults, the Danish…
Reuters Health Information